Glaxo’s Ex-China Head Reilly to Return as Part of Bribery Probe
This article is for subscribers only.
GlaxoSmithKline Plc’s former China head, Mark Reilly, will return to the country soon to assist with a government investigation into allegations of bribery.
The company’s global audit team, security personnel and senior lawyers will also go to Shanghai, China’s Ministry of Public Security said in a statement dated yesterday. The ministry said it welcomes the actions and hopes the unit will resume production and operation as soon as possible.